tiprankstipranks
Affimed Therapeutics (AFMD)
:AFMD
US Market

Affimed (AFMD) Technical Analysis

Compare
846 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
6Neutral
14Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Affimed Therapeutics’s (AFMD) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting Affimed Therapeutics is a Sell.
Affimed Therapeutics’s (AFMD) 20-Day exponential moving average is 1.08, while Affimed Therapeutics’s (AFMD) share price is $1.02, making it a Sell.
Affimed Therapeutics’s (AFMD) 50-Day exponential moving average is 1.44, while Affimed Therapeutics’s (AFMD) share price is $1.02, making it a Sell.

Affimed (AFMD) Pivot Points

Feb 22, 2025, 03:38 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.00
1.03
1.04
1.07
1.08
1.11
1.12
Fibonacci
1.03
1.04
1.05
1.07
1.08
1.09
1.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Affimed (AFMD) Moving Averages

Feb 22, 2025, 03:38 AM
Period
Simple
Exponential
MA5
1.05Sell
1.04Sell
MA10
1.05Sell
1.04Sell
MA20
1.04Sell
1.08Sell
MA50
1.29Sell
1.44Sell
MA100
2.25Sell
2.13Sell
MA200
3.58Sell
3.31Sell
Affimed Therapeutics’s (AFMD) 10-Day exponential moving average is 1.04, while Affimed Therapeutics’s (AFMD) share price is $1.02, making it a Sell.
Affimed Therapeutics’s (AFMD) 100-Day exponential moving average is 2.13, while Affimed Therapeutics’s (AFMD) share price is $1.02, making it a Sell.
Affimed Therapeutics’s (AFMD) stock price is $1.02 and Affimed Therapeutics’s (AFMD) 50-day simple moving average is 1.29, creating a Sell signal.
Affimed Therapeutics’s (AFMD) stock price is $1.02 and Affimed Therapeutics’s (AFMD) 100-day simple moving average is 2.25, creating a Sell signal.
Affimed Therapeutics’s (AFMD) stock price is $1.02 and Affimed Therapeutics’s (AFMD) 200-day simple moving average is 3.58, creating a Sell signal.

Affimed (AFMD) Technical Indicators

Feb 22, 2025, 03:38 AM
Name
Value
Implied Action
RSI (14)
35.84
Neutral
STOCH (9,6)
63.64
Neutral
STOCHRSI (14)
73.53
Neutral
MACD (12,26)
-0.08
Sell
ADX (14)
30.21
Neutral
Williams %R
-50.00
Buy
CCI (14)
-15.07
Neutral
ATR (14)
0.08
-
Ultimate Oscillator
53.66
Neutral
ROC
4.08
Buy
Affimed Therapeutics’s (AFMD) Relative Strength Index (RSI) is 35.84, creating a Neutral signal.
Affimed Therapeutics’s (AFMD) Trend Strength Indicator (ADX) is 30.21, creating a Neutral signal.
Affimed Therapeutics’s (AFMD) Commodity Channel Index (CCI) is -15.07, creating a Neutral signal.
Affimed Therapeutics’s (AFMD) Price Rate of Change (ROC) is 4.08, creating a Buy signal.

FAQ

Is AFMD a Buy, Hold, or Sell?
Based on AFMD’s technical indicators, AFMD is a Strong Sell.
    What is AFMD’s RSI (14)?
    AFMD’s RSI (14) is 35.84, which suggests AFMD is a Neutral.
      What is AFMD’s MACD?
      AFMD’s MACD is -0.08, which suggests AFMD is a Sell.
        What is AFMD’s 5-day moving average?
        AFMD’s 5-day moving average is 1.05, which suggests AFMD is a Sell.
          What is AFMD’s 20-day moving average?
          AFMD 20-day moving average is 1.04, which suggests AFMD is a Sell.
            What is AFMD’s 50-day moving average?
            AFMD’s 50-day moving average is 1.29, which suggests AFMD is a Sell.
              What is AFMD’s 200-day moving average?
              AFMD’s 200-day moving average is 3.58, which suggests AFMD is a Sell.
                What is AFMD’s Williams % R (14)?
                AFMD’s Williams % R (14) is -50.00, which suggests AFMD is a Buy.
                  What is AFMD’s CCI (14)?
                  AFMD’s CCI (14) is -15.07, which suggests AFMD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis